Alzheimer’s: Delhi pharma company gets Bengaluru scientists’ drug candidate
Hamsa Biopharma, which will take the drug — Christened TGR63 — to trials through its parent company in the US, IGC Pharma, hopes it can eventually be made available in the market.
Scientists discover possible drug target for Alzheimer’s
Researchers in India say they have discovered a promising drug target that may slow or even halt the progression of Alzheimer’s.
Weed 3 the Marijuana Revolution
